Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/22/1995 | EP0643969A2 Pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis |
03/22/1995 | EP0643968A1 Molded pharmaceutical form for oral delivery of acetylsalicyclic acid or its salts and method to prepare it |
03/22/1995 | EP0643967A2 Pharmaceutical compositions containing analgesic, e.g. morphine, and a laxative, e.g. bisacodyl |
03/22/1995 | EP0643965A1 Nicotinic acid compositions for treating hyperlipidemia |
03/22/1995 | EP0643964A2 Use of local anesthetics for the manufacture of a medicament for the protection of plasma cell membranes |
03/22/1995 | EP0643962A1 New galenic dosage form for phloroglucinol |
03/22/1995 | EP0643959A1 Use of 13-transretinoic acid esters for the treatment of skin cancer and photoaging |
03/22/1995 | EP0643780A1 Multiple solvent cleaning system. |
03/22/1995 | EP0643775A1 Therapeutic compositions |
03/22/1995 | EP0643767A1 Osteogenic peptides |
03/22/1995 | EP0643718A1 IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWIS?C AND LacNAc COMPOUNDS |
03/22/1995 | EP0643716A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism |
03/22/1995 | EP0643713A1 Pyrrolo(1,2-b)-(1,2)-benzothiazin-10-one and its use as an antimicrobial |
03/22/1995 | EP0643712A1 Spiro-oxetanes, process for preparing the same and medicaments |
03/22/1995 | EP0643709A1 4-(1-$i(H)-PYRROL-1-YL)IMIDAZOLES WITH ANGIOTENSIN II ANTAGONIST ACTIVITY |
03/22/1995 | EP0643705A1 PROCESS FOR PRODUCING N-$g(b)-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,7,10-TETRAAZACYCLODODECANE AND N-$g(b)-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AND THEIR METAL COMPLEXES |
03/22/1995 | EP0643701A1 Benzimidazole-derived compounds, method for preparing same, and therapeutical and cosmetic uses thereof |
03/22/1995 | EP0643696A1 Azavesamicols |
03/22/1995 | EP0643693A1 Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
03/22/1995 | EP0643692A1 High cis beta-carotene composition |
03/22/1995 | EP0643690A1 Desferrioxamine-b salts and their use as orally effective iron chelators |
03/22/1995 | EP0643688A1 Substituted (arylalkoxybenzyl)aminopropanamide derivatives, their preparation and use as anti-epileptic, neuroprotective and antidepressant agents |
03/22/1995 | EP0643686A1 New compounds |
03/22/1995 | EP0643581A1 Ocular androgen therapy in sjögren's syndrome |
03/22/1995 | EP0643580A1 Combinations of ace inhibitors and diuretics |
03/22/1995 | EP0643579A1 Triazole substituted quinoline derivatives |
03/22/1995 | EP0643578A1 A new composition containing selegiline |
03/22/1995 | EP0643577A1 Use of aminothiophenols in the treatment of disorders associated with the complement system |
03/22/1995 | EP0643576A1 Alpha-2-adrenergic agonists for treating presbyopia |
03/22/1995 | EP0643575A1 Metering spray designed for pernasal application. |
03/22/1995 | EP0585355B1 Multi-layered controlled release formulation |
03/22/1995 | EP0561861B1 A process for the preparation of diltiazem |
03/22/1995 | EP0561846B1 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities |
03/22/1995 | EP0557301B1 5-fluoro-2,4,6-pyrimidinetriamine compounds for preventing hair loss |
03/22/1995 | EP0471856B1 15-deoxyprostaglandin derivative |
03/22/1995 | EP0357646B1 Treatment of aged skin with oral 13-cis-retinoic acid |
03/22/1995 | CN1100467A 1-N-ethyl gentamicin derivative and its preparing method |
03/22/1995 | CN1100426A Lysosomal enzyme-cleavable antitumor drug conjugates |
03/22/1995 | CN1100424A Pyridoindolobenzodiazepines and derivatives as antipsychotics |
03/22/1995 | CN1100423A Novel derivative of benoxazine and pharmaceutical composition containing same |
03/22/1995 | CN1100422A Novel derivative of benoxazine and pharmaceutical composition containing same |
03/22/1995 | CN1100421A Process for preparation of a pharmaceutical composition containing a triazole derivative |
03/22/1995 | CN1100420A 2,6-disubstituted 4-quinolyl-dihydropyridines |
03/22/1995 | CN1100419A 3-quinolyl-substituted dihydropyridines, process for their preparation and their use in medicaments |
03/22/1995 | CN1100418A 2-amino-5-cyano-4-quinolyldihydropyridine esters, processes for their preparation and their use in medicaments |
03/22/1995 | CN1100417A N-heteroaryl-n'-phenylurea derivatives, their production and use |
03/22/1995 | CN1100416A Derivative of 2-amino-N-ÛÛÛ4-(aminocarbonyl)pyrimidin-2-ylÙamizoÙalkylÙpyrimidiny-4-carboxamide, preparation and pharmaceutical application of same |
03/22/1995 | CN1100415A New preparation process for sulphurated derivatives of imidazole and the new intermediates obtained |
03/22/1995 | CN1100414A Preparation of pharmaceutical compound containing novel derivative of leukol |
03/22/1995 | CN1100413A Urethanes and ureas that induce cytokine production |
03/22/1995 | CN1100408A Pentanoic acid derivatives |
03/22/1995 | CN1100307A Polyvitmin active calcium and its preparing method |
03/22/1995 | CN1100306A Compound zinc gluconate capsules, tablets and buccal tablets and their preparing method |
03/22/1995 | CN1100305A Medicine for preventing & curing silkworm's pyemia |
03/22/1995 | CN1100304A Dihydropyridine-antihypertensive medicine |
03/22/1995 | CN1100303A L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents |
03/22/1995 | CN1100302A Inhibition and treatment of infection by enveloped virus with calix(n)arene compounds |
03/22/1995 | CN1100301A Drug for neuroprotection |
03/22/1995 | CN1027959C Zinc-calcium oral liquid and its preparation |
03/22/1995 | CA2132489A1 Eosinophil chemotaxis inhibitor |
03/22/1995 | CA2132479A1 Pharmaceutical composition for treating or preventing allergic rhinitis |
03/22/1995 | CA2131749A1 Cyclohexane derivatives |
03/21/1995 | US5399785 Tyrosinase activity inhibitor |
03/21/1995 | US5399748 Derivatives of aspartic acid and glutamic acid having anticholecystokinin activity |
03/21/1995 | US5399743 Osteoporosis, hypercalcemia |
03/21/1995 | US5399741 DNA gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same |
03/21/1995 | US5399723 Bactericide active against methicillin resistant Staphylococcus aureus |
03/21/1995 | US5399719 Compounds for the photodecontamination of pathogens in blood |
03/21/1995 | US5399714 One-pot reduction; acylation |
03/21/1995 | US5399711 Thiomarinol compounds |
03/21/1995 | US5399703 Tetrazole derivatives and drugs |
03/21/1995 | US5399702 Leukotriene antagonists; antiasthmatic, antiallergen, and antianaphylactic agents |
03/21/1995 | US5399700 Method for preparing enteric-coated oral drugs containing acid-unstable compounds |
03/21/1995 | US5399698 Quinolin-2-yl-methoxybenzylhydroxyureas |
03/21/1995 | US5399696 Excitatory amino acid receptor antagonists; nervous system disorders |
03/21/1995 | US5399694 Antitumor |
03/21/1995 | US5399693 Substituted piperazine-2-carboxylic acids and derivatives thereof |
03/21/1995 | US5399691 Antitumor agents |
03/21/1995 | US5399686 Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
03/21/1995 | US5399675 Acidic polycyclic ether antibiotics and microorganisms useful in the production thereof |
03/21/1995 | US5399672 Coupling hapten to protein or polypeptide in solvent |
03/21/1995 | US5399590 Treatment of skin tumors, rheumatic diseases |
03/21/1995 | US5399587 Biologically active compounds |
03/21/1995 | US5399586 Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity |
03/21/1995 | US5399584 Preventing gastrointestinal damage caused by nonsteroidal antiinflammatory drugs |
03/21/1995 | US5399582 Antiparasitic agents |
03/21/1995 | US5399581 Administering mixture of nonselective alpha 1-alpha 2, and beta adrenergic blocking agents having vasodilator activity |
03/21/1995 | US5399580 Viricides for hepatitis B |
03/21/1995 | US5399578 Acyl compounds |
03/21/1995 | US5399576 Thiazoles |
03/21/1995 | US5399575 Pyridine compounds which have useful pharmaceutical activity |
03/21/1995 | US5399574 5-hydroxytryptamine agonists; vasoconstrictors |
03/21/1995 | US5399573 Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract |
03/21/1995 | US5399572 Chlormethiazole in the treatment of neurodegeneration |
03/21/1995 | US5399571 Neuroprotective drug |
03/21/1995 | US5399570 Aspartic acid derivatives, and their use for inhibiting platelete aggregation |
03/21/1995 | US5399569 Salts of 3-(cis-2,6-dimethylpiperidino) sydnone imine |
03/21/1995 | US5399568 Dopamine antagonists |
03/21/1995 | US5399567 Method of treating cholera |
03/21/1995 | US5399563 Benzylidenequinuclidinones |